This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
TriMas (TRS) Acquires Affaba & Ferrari, Expands Product Offering
by Zacks Equity Research
The latest acquisition will help TriMas (TRS) strengthen its existing food and beverage, and industrial product lines.
Strong Equipment Demand & Farming Innovations Aid Deere (DE)
by Zacks Equity Research
Deere (DE) is benefiting from the stellar farming outlook for fiscal 2021 as well as robust farm equipment demand.
Sonoco (SON) Hikes Prices for Rigid Paper Containers & Closures
by Zacks Equity Research
Sonoco (SON) is implementing price-increase actions for all North American rigid paper containers and closures in response to the rapidly-increasing raw-material costs.
4 Top Industrial Stocks Set to Finish 2020 on a Stellar Note
by Namrata Chatterjee
As the U.S. manufacturing sector continues to expand for the sixth straight month, we suggest four lucrative industrial stocks with positive growth projections for your portfolio.
Here's Why You Should Bet on Sealed Air (SEE) Stock Now
by Zacks Equity Research
Focus on product innovation and acquisitions, upbeat growth prospects for 2020 and beyond make Sealed Air (SEE) stock a compelling investment choice at the moment.
Crown Holdings (CCK) Gains From Solid Beverage-Can Demand
by Zacks Equity Research
Crown Holdings (CCK) is benefiting from the rising global beverage-can demand as consumers are favoring cans over other packaging options.
Zacks.com featured highlights include: Regions Financial, Mohawk Industries, Asbury Automotive, Silgan Holdings and DCP Midstream
by Zacks Equity Research
Zacks.com featured highlights include: Regions Financial, Mohawk Industries, Asbury Automotive, Silgan Holdings and DCP Midstream
Here's Why You Should Invest in Silgan (SLGN) Stock Now
by Zacks Equity Research
Demand for essential products, cost-containment actions and solid estimate revision activity make Silgan (SLGN) a prudent investment option.
3 Reasons Why Growth Investors Shouldn't Overlook Silgan (SLGN)
by Zacks Equity Research
Silgan (SLGN) possesses solid growth attributes, which could help it handily outperform the market.
5 Stocks With Upgraded Broker Ratings Worth Investing in Now
by Swayta Shah
When a broker upgrades a stock, one can rely on their judgment. So, we select Regions Financial (RF), Mohawk Industries (MHK), Asbury Automotive (ABG), Silgan Holdings (SLGN) & DCP Midstream (DCP) as these witness ratings upgrade.
7 Valuable Low Price-to-Sales Stocks With Potential to Grow
by Zacks Equity Research
A stock with a lower price-to-sales ratio is a more suitable investment than a stock with a high price-to-sales ratio.
Is Silgan Holdings (SLGN) Stock Outpacing Its Industrial Products Peers This Year?
by Zacks Equity Research
Is (SLGN) Outperforming Other Industrial Products Stocks This Year?
Using ROE to Select Stocks
by Sejuti Banerjea
Clubbing ROE with the Zacks Rank, industry rank and other criteria is a neat way to select stocks.
Zacks.com featured highlights include: Westlake Chemical Partners, Silgan Holdings, Standard Motor, ePlus and AAR Corp
by Zacks Equity Research
Zacks.com featured highlights include: Westlake Chemical Partners, Silgan Holdings, Standard Motor, ePlus and AAR Corp
7 Stocks With Low Price-to-Sales That Are Worth Betting On
by Rajani Lohia
A stock's price-to-sales ratio reflects how much investors are paying for each dollar of revenues generated by a company.
Silgan (SLGN) Q3 Earnings Beat, Stock Down on Weak Q4 View
by Zacks Equity Research
Silgan (SLGN) delivers better-than-expected third-quarter results on solid demand for food, health and hygiene products amid the COVID-19 pandemic.
AptarGroup (ATR) Suffers From Weak End Markets Amid Pandemic
by Zacks Equity Research
AptarGroup's (ATR) third-quarter 2020 results are likely to reflect higher demand for pharmaceutical products amid the COVID-19 pandemic. However, weak beauty products sales will negate these gains.
Avery Dennison (AVY) Q3 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Avery Dennison (AVY) reports year-over-year improvement in third-quarter 2020 earnings despite decline in revenues, primarily driven by cost reduction initiatives.
Crown (CCK) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Crown (CCK) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Silgan Holdings (SLGN) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Silgan (SLGN) delivered earnings and revenue surprises of 9.47% and 2.34%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Pentair (PNR) Beats on Q3 Earnings & Sales, Ups '20 View
by Zacks Equity Research
Pentair (PNR) delivers better-than-expected third-quarter performance and projects adjusted earnings per share (EPS) between $2.35 and $2.40 for the current year.
Should You Buy Silgan (SLGN) Ahead of Earnings?
by Zacks Equity Research
Silgan (SLGN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
The Zacks Analyst Blog Highlights: Abbott Laboratories, NextEra Energy, Silgan Holdings, UniFirst Corp and Landstar System
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Abbott Laboratories, NextEra Energy, Silgan Holdings, UniFirst Corp and Landstar System
An Investment Strategy for Q3 Earnings in a Volatile Market
by Nalak Das
Investment in low-beats stocks with a favorable Zacks Rank and positive Earnings ESP will be a sound strategy to enhance one's portfolio.
Silgan Holdings (SLGN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Silgan (SLGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.